Phage therapy holds promise in fighting against antimicrobial resistance: Dr. Kalyan Chakravarthy

GUNTUR Phage therapy, which uses bacteriophages to selectively eliminate harmful bacteria, holds significant potential in combating antimicrobial resistance (AMR), said Dr. Kalyan Chakravarthy Koganti, sepsis and infectious diseases specialist at SHRI Hospital, Guntur. He said this while sharing his research experience in a press release, after presenting his team's scientific findings at an international symposium jointly organised by the Chinese University of Hong Kong and reputed biomedical research journals.

Dr. Kalyan Chakravarthy said his team's research presentation on phage therapy received appreciation from participants at the symposium. Dr.

Sutharsan Govindarajan, Associate Professor and phage biologist, SRM University, AP, also presented research conducted by the team. He described the event as an enriching learning experience, particularly the discussions on the wider applications of bacteriophages in diagnostics and therapy, including cancer research.